lifestyle.phenomena.org

Author: Boehringer Ingelheim Limited

Global survey reveals pet owners lack awareness of parasite risks and seek clearer prevention advice

March 18, 2026
Boehringer Ingelheim’s investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial

January 28, 2026
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

January 27, 2026